Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$115.60
0.640.56%
Last update: 2:04 PM
15 minutes delayed
Comments
Loading...
Merck & Co (MRK) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesGovernment TradesShort InterestOverview Rating
Speculative
Merck & Co (NYSE:MRK) Stock Quotes, Forecast and News Summary
Merck & Co Stock (NYSE: MRK) stock price, news, charts, stock research, profile.
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Merck & Co (MRK) stock?
You can purchase shares of Merck & Co (NYSE:MRK) through any online brokerage.
Who are Merck & Co (MRK) competitors?
Other companies in Merck & Co’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Pfizer (NYSE:PFE) and Axsome Therapeutics (NASDAQ:AXSM).
What is the forecast, or price target, for Merck & Co (MRK) stock?
Merck & Co has a consensus price target of $127.68.
What is the current price for Merck & Co (MRK)?
The stock price for Merck & Co (NYSE: MRK) is $115.6 last updated September 25, 2024 at 2:04 PM EDT.
Does Merck & Co (MRK) pay a dividend?
A quarterly cash dividend of 0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2024 to stockholders of record on September 16, 2024.
When is Merck & Co (NYSE:MRK) reporting earnings?
Merck & Co’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Merck & Co (MRK) going to split?
There is no upcoming split for Merck & Co.
What sector and industry does Merck & Co (MRK) operate in?
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.